Online Only Articles

Low-dose methotrexate in myeloproliferative neoplasm models

The Bateson Centre, Department of Biomedical Science, The University of Sheffield, UK
Department of Oncology & Metabolism, The University of Sheffield, UK
The Bateson Centre, Department of Biomedical Science, The University of Sheffield, UK
Department of Oncology & Metabolism, The University of Sheffield, UK
Department of Oncology & Metabolism, The University of Sheffield, UK
Department of Oncology & Metabolism, The University of Sheffield, UK
Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust, UK
Cambridge Stem Cell Institute, Cambridge institute for Medical Research and Department of Haematology, University of Cambridge, UK
Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, UK
Department of Oncology & Metabolism, The University of Sheffield, UK;Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, UK
The Bateson Centre, Department of Biomedical Science, The University of Sheffield, UK
Vol. 102 No. 9 (2017): September, 2017 https://doi.org/10.3324/haematol.2017.165738